Cargando…
A4 Development of HIV drug resistance in HIV-infected patients failing second line regimen in Zimbabwe: A public health concern
Autores principales: | Kouamou, V, Katzenstein, D, Shamu, T, Chimbetete, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905438/ http://dx.doi.org/10.1093/ve/vey010.003 |
Ejemplares similares
-
HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe
por: Chimbetete, Cleophas, et al.
Publicado: (2018) -
A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria
por: James, Onyemata E., et al.
Publicado: (2017) -
A18 HIV-1 genetic diversity and drug resistance in Haiti
por: Delva, G, et al.
Publicado: (2018) -
A13 HIV drug resistance over a decade of antiretroviral therapy scale-up for HIV/AIDS patients in Vietnam
por: Nguyen, L.A., et al.
Publicado: (2017) -
A13 HIV drug resistance over a decade of antiretroviral therapy scale-up for HIV/AIDS patients in Vietnam
por: Nguyen, L.A., et al.
Publicado: (2017)